May 2021 - Evolution Biotechnologies
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

21 May

Posted at 13:26h in News by
1 Like

Evolution Biotechnologies announces the publication of its paper “Biological Control of the House Dust Mite, With Potential For Use in the Prevention of Asthma” in the International Journal of Advances in Science Engineering and Technology Bedford, UK, May 17th 2021 Evolution Biotechnologies (www.evolutionbiotech.com), the UK based company pioneering the use of biological control to benefit human health, today announced the publication of its paper “Biological Control of the House Dust Mite, With Potential For Use in the Prevention of Asthma” in the International Journal of Advances in Science Engineering and Technology, volume 8, issue 3. The paper is now available online at http://www.iraj.in/journal/journal_file/journal_pdf/6-661-162020261360-64.pdf Dr....

21 May

Posted at 13:20h in News by
0 Likes

Australian Patent Office announces intention to grant Evolution Biotechnologies Patent No. 2016305553, “Acaricides” Bedford, UK, May 17th 2021 Evolution Biotechnologies (www.evolutionbiotech.com), the UK based company pioneering the use of biological control to benefit human health, today announced that it has been notified by the Australian Patent Office of their intention to grant Patent Application No. 2016305553, “Acaricides”, deriving from WO2017025732A1, This will provide broad protection for both formulation and use of Evolution’s biological control technology for house dust mites in the control of asthma and other allergic diseases in Australia, which has a very high rate of asthma among its population. As a result...